ARCHIVES

NCI To Fund About 4,100 Grants; Increase Planned In Average Costs; Paylines Stable

This article is from The Cancer Letter archive.

Vol. 24 No. 44 | November 20, 1998

Download PDF Visit The Full Archive

Related Articles

Sprycell Approved for CML

November 5, 2010

Tarceva Reaches Endpoint Early: Longer PFS Than Chemo Alone

February 25, 2011

Novartis Begins Study Of Femara And Zometa In Postmenopausal Early Breast Cancer

December 27, 2002

Guest Editorial: A Near-Term Solution: NCI And COG Agree on Plan to Maintain Enrollment

May 23, 2014

Pharmaceutical Industry: IVAX Official Broder Objects To Orphan Drug Policies of FDA

May 9, 1997

Edward Harlow Returns to NCI As Special Assistant to Varmus

January 14, 2011